Trademark: 97931193
Word
TEAM INTELLIGENCE
Status
Pending
Status Code
686
Status Date
Tuesday, September 10, 2024
Serial Number
97931193
Mark Type
4
Filing Date
Thursday, May 11, 2023
Published for Opposition
Tuesday, September 10, 2024

Trademark Owner History
ViroCell Biologics Ltd - Owner At Publication

Classifications
40 Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents
5 Pharmaceutical preparations, biological preparations, and gene therapy pharmaceutical and biological products for medical or pharmaceutical purposes, namely, gene therapies, viral vectors, DNA plasmids, and nucleic-acid delivery products all for use in the treatment of genetic diseases and disorders
42 Product development for others relating to pharmaceuticals, biopharmaceuticals, health care products and medical products; scientific and technological consulting services in the pharmaceutical industry, and research and design relating thereto; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development

Trademark Events
Feb 6, 2024
Notification Of Non-Final Action E-Mailed
Jun 10, 2023
New Application Office Supplied Data Entered
Feb 6, 2024
Assigned To Examiner
Feb 6, 2024
Non-Final Action Written
Feb 6, 2024
Non-Final Action E-Mailed
May 6, 2024
Application Extension To Response Period - Received
May 6, 2024
Application Extension Granted/Receipt Provided
Aug 6, 2024
Correspondence Received In Law Office
Aug 6, 2024
Teas Response To Office Action Received
Aug 7, 2024
Teas/Email Correspondence Entered
Aug 8, 2024
Approved For Pub - Principal Register
Aug 21, 2024
Notification Of Notice Of Publication E-Mailed
Sep 10, 2024
Published For Opposition
Sep 10, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24